Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 9, 2017

View Archived Issues

Ono reviews developments of second quarter of fiscal 2017

Sanofi presents key product and pipeline events of third quarter 2017

FDA clears Sarepta Therapeutics' IND for DMD candidate

OncoResponse completes acquisition of Paganini Biopharma

NX-AS-401 enhances the antibiotic effect of tobramycin in vitro and in vivo

FDA grants RMAT designation to Cellvation's CEVA-101

Invirsa closes seed financing to develop INV-102

Synlogic's SYNB-1020 demonstrates safety and tolerability in phase I study

CRISPR/Cas technology used to target HPV oncoprotein E6 for cervical cancer

Long-lasting enhancement of cognitive capabilities using AAV vector expressing the Klotho gene

Nightstar Therapeutics licenses gene therapy for Stargardt disease

Sosei gains Japanese license to HTL-0018318 for dementia with Lewy bodies under Allergan partnership

Torrent Pharmaceuticals discloses novel PI3K inhibitors

Boehringer Ingelheim initiates first-in-human study of BI-894416

ApoGlyx divulges new AQP9 inhibitors

Millendo Therapeutics reports topline phase II results on ATR-101, discontinues MLE-4901

AstraZeneca conducts phase I trial of MEDI-1341

Novartis reports topline results from MONALEESA-7 study of Kisqali

Viiv conducts first-in-human study of maturation inhibitor GSK-3640254

Bristol-Myers Squibb identifies Nav1.7 channel blockers

Synermore compares safety and pharmacokinetics of SYN-060 to Humira

Samumed presents DYRK1A, GSK-3beta and IL-6 production inhibitors

Trial data reported for dabrafenib/trametinib/navitoclax in BRAF-mutant solid tumor patients

Rexahn Pharmaceuticals doses first patient in phase IIa study of RX-3117 plus Abraxane

HSP 90 inhibitors presented by Duke University

Novita initiates phase I study of NP-G2-044 in advanced or metastatic solid tumors

FDA approves Prevymis for CMV prevention in adult HSCT recipients

Neurimmune collaborates with Ono on discovery of antibodies for neurodegenerative diseases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...